KGC Sang-A to introduce influenza vaccine FluMist

Published: 2003-09-24 06:55:00

Updated: 2003-09-24 06:55:00

Korea Green Cross Sang-A Pharm said it would distribute in Korea FluMist (influenza virus vaccine from next year, internasal), which was approved by the U.S. Food and Drug Administration as the first influenza vaccine delivered as a nsal mist available in the United States for health people.

...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK